Peter T. Daley‐Yates

机构：GlaxoSmithKline (United Kingdom) · ORCID：0000-0003-0684-5621

发表论文 108 篇 · 总被引 3152 次 · h-index 33

代表论文

Inhaled corticosteroids: potency, dose equivalence and therapeutic index (2015 · British Journal of Clinical Pharmacology · 被引 265)
Therapeutic index of inhaled corticosteroids in asthma: A dose–response comparison on airway hyperresponsiveness and adrenal axis suppression (2020 · British Journal of Clinical Pharmacology · 被引 87)
Pharmacokinetic, pharmacodynamic, efficacy, and safety data from two randomized, double-blind studies in patients with asthma and an in vitro study comparing two dry-powder inhalers delivering a combination of salmeterol 50 μg and fluticasone propionate 250 μg: Implications for establishing bioequivalence of inhaled products (2009 · Clinical Therapeutics · 被引 47)
Intranasal Corticosteroids: Topical Potency, Systemic Activity and Therapeutic Index (2021 · Journal of Asthma and Allergy · 被引 46)
Role of Pharmacokinetics in Establishing Bioequivalence for Orally Inhaled Drug Products: Workshop Summary Report (2011 · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 被引 44)
Pharmacokinetics and Pharmacodynamics of Fluticasone Propionate and Salmeterol Delivered as a Combination Dry Powder from a Capsule-Based Inhaler and a Multidose Inhaler in Asthma and COPD Patients (2013 · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 被引 36)